ARROWHEAD PHARMACEUTICALS, INC. Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31)
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) had Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) of $1.60 million as of 2013-09-30, per its 10-K filed 2013-12-18.
Discontinued › Notes › Business Combinations
us-gaap:BusinessAcquisitionContingentConsiderationAtFairValue · last filed 2013-12-18
- 2013-09-30: Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) $1.60M.
- 2013-06-30: Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) $173.62K.
- 2013-03-31: Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) $173.62K.
- 2012-12-31: Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) $173.62K.
| Period end | Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) |
|---|---|
| 2013-09-30 | $1.60M 10-K · filed 2013-12-18 |
| 2013-06-30 | $173.62K 10-Q · filed 2013-08-07 |
| 2013-03-31 | $173.62K 10-Q · filed 2013-05-09 |
| 2012-12-31 | $173.62K 10-Q · filed 2013-02-13 |
| 2012-09-30 | $173.62K 10-K · filed 2013-12-18 |
| 2011-09-30 | $0.00 10-Q · filed 2013-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |